Check out the companies making the biggest moves premarket: Goldman Sachs — Shares fell more than 2% despite the bank reporting an earnings and revenue beat in its first quarter report, thanks to record equities trading and stronger investment banking revenues. Goldman reported $17.55 in earnings per share and $17.23 billion in revenue, better than the consensus estimates of $16.49 in earnings and $16.97 billion in revenue, according to LSEG. Trading in its fixed income, currencies and commodities unit was $4.01 billion, well short of the $4.92 billion consensus estimate for FICC trading from analysts polled by FactSet. Revolution Medicines — The stock surged more than 37% after it was revealed its drug for pancreatic cancer succeeded in a phase 3 trial. The company said the daily pill, daraxonrasib, led patients to live 13.2 months versus those who used chemotherapy who lived 6.7 months. Williams-Sonoma — The kitchen and cookware retailer gained more than 2% after getting an upgrade to buy at Goldman Sachs. Analysts at the bank said the stock is trading at attractive levels, adding Williams-Sonoma has “one of the strongest portfolio of brands in retail.” Best Buy — Goldma …
